A licensed provider through Hims can guide you on how to incorporate them in a way that works for your goals
Titration curves matter more than compound choice for tolerability outcomes
Tirzepatide 15 mg was also associated with higher incidence of vomiting (OR 5.50 [95% CI 2.40, 12.59], I 2 0%) and diarrhoea (OR 3.31 [95% CI 1.40, 7.85], I 2 52%), while more participants receiving tirzepatide 10 mg experienced vomiting (OR 2.98 [95% CI 1.13, 7.80], I 2 0%) (Table 2)
Toronto 2011
BPC-157 restores blood flow and builds the vascular foundation that injured tissue needs before structural repair can begin
2 The cardiovascular licence applies to adults who: have established cardiovascular disease, such as a previous heart attack, stroke, or narrowed arteries have a BMI of 27 or above The licence is based on the SELECT trial, a Phase 3 study (a large human trial with thousands of participants)